330 related articles for article (PubMed ID: 17258690)
1. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR;
Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690
[TBL] [Abstract][Full Text] [Related]
2. Topiramate for binge-eating disorder associated with obesity.
Tata AL; Kockler DR
Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial.
Guerdjikova AI; McElroy SL; Welge JA; Nelson E; Keck PE; Hudson JI
Int Clin Psychopharmacol; 2009 May; 24(3):150-8. PubMed ID: 19357528
[TBL] [Abstract][Full Text] [Related]
5. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.
Kotwal R; Guerdjikova A; McElroy SL; Keck PE
Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
Rosenstock J; Hollander P; Gadde KM; Sun X; Strauss R; Leung A;
Diabetes Care; 2007 Jun; 30(6):1480-6. PubMed ID: 17363756
[TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
[TBL] [Abstract][Full Text] [Related]
8. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
Dalai SS; Adler S; Najarian T; Safer DL
Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
[TBL] [Abstract][Full Text] [Related]
9. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
[TBL] [Abstract][Full Text] [Related]
10. Topiramate use in obese patients with binge eating disorder: an open study.
Appolinario JC; Fontenelle LF; Papelbaum M; Bueno JR; Coutinho W
Can J Psychiatry; 2002 Apr; 47(3):271-3. PubMed ID: 11987480
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
Wilfley DE; Crow SJ; Hudson JI; Mitchell JE; Berkowitz RI; Blakesley V; Walsh BT;
Am J Psychiatry; 2008 Jan; 165(1):51-8. PubMed ID: 18056225
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension.
Tonstad S; Tykarski A; Weissgarten J; Ivleva A; Levy B; Kumar A; Fitchet M
Am J Cardiol; 2005 Jul; 96(2):243-51. PubMed ID: 16018851
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
15. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.
Bray GA; Hollander P; Klein S; Kushner R; Levy B; Fitchet M; Perry BH
Obes Res; 2003 Jun; 11(6):722-33. PubMed ID: 12805393
[TBL] [Abstract][Full Text] [Related]
16. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review.
Arbaizar B; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2008; 30(5):471-5. PubMed ID: 18774432
[TBL] [Abstract][Full Text] [Related]
18. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S
Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
[TBL] [Abstract][Full Text] [Related]
20. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
